lifestyle.goodsciencing.com

Author: Faron Pharmaceuticals

Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer

December 22, 2025
Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board

December 17, 2025
Faron Presents Updated BEXMAB Data at ASH 2025: Deep and Durable Responses in HR-MDS with Favorable Safety Profile

December 8, 2025